• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

What is the role of FDA's Office of Orphan Product Development and Office of New Drugs?

Nearly 30 million individuals are affected by rare diseases in the United States. A disease is considered rare if it affects fewer than 200,000 within the United States and there are more than 7000 such diseases and conditions. Rare diseases in childhood can be debilitating and require lifelong care. FDA’s Office of Orphan Product Development and Office of New Drugs facilitate the development and improve availability of treatment products for all patients including children with rare diseases.
Here are the resources to help you to find out more about orphan drug development:
 

Basics Question toggle Show all related FDA Basics Questions

-

How helpful was this information?

                               

Not HelpfulArrow pointing to the rightVery Helpful


Please limit your feedback to 1000 characters.

Please limit your feedback to 1000 characters.

If you would like to ask a specific question, please visit our "Contact Us" page for more information about how to contact FDA.

Please note that any information you submit may become public or subject to release under the Freedom of Information Act (FOIA). For more information, read about our privacy policies and the FOIA.

-